Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS – Research Report) and Thermo Fisher (TMO – Research Report).
Pyxis Oncology (PYXS)
Bank of America Securities analyst Tazeen Ahmad reiterated a Hold rating on Pyxis Oncology yesterday and set a price target of $4.00. The company’s shares closed last Wednesday at $3.34.
According to TipRanks.com, Ahmad is a 5-star analyst with an average return of
Currently, the analyst consensus on Pyxis Oncology is a Moderate Buy with an average price target of $10.00.
See the top stocks recommended by analysts >>
Thermo Fisher (TMO)
In a report released yesterday, Derik De Bruin from Bank of America Securities maintained a Buy rating on Thermo Fisher, with a price target of $650.00. The company’s shares closed last Wednesday at $510.72.
According to TipRanks.com, Bruin is a 4-star analyst with an average return of
Thermo Fisher has an analyst consensus of Strong Buy, with a price target consensus of $645.00, a 26.5% upside from current levels. In a report issued on May 15, RBC Capital also maintained a Buy rating on the stock with a $662.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PYXS:
